AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
07 May 2014 11:00 AM
RNS
Rule 2.10 Announcement
06 May 2014 04:02 PM
BZW
Form 8.3 - ASTRAZENECA PLC
06 May 2014 03:30 PM
RNS
Changes to membership of Board Committees
06 May 2014 03:12 PM
BZW
Form 8.3 - AstraZeneca Plc
06 May 2014 01:12 PM
BZW
Form 8.3 - AstraZeneca PLC
06 May 2014 01:10 PM
BZW
Form 8.3 - AstraZeneca PLC
06 May 2014 12:31 PM
BZW
Form 8.3 - Astrazeneca Plc
06 May 2014 11:30 AM
RNS
Rule 2.10 Announcement
06 May 2014 11:00 AM
RNS
ASTRAZENECA ISSUES UPDATE ON STRATEGY
06 May 2014 07:01 AM
RNS
US FDA APPROVES EPANOVA
06 May 2014 07:00 AM
BZW
Form 8.3 - Astrazeneca - Amendment
06 May 2014 07:00 AM
BZW
Form 8.3 - AstraZeneca Plc
02 May 2014 04:07 PM
BZW
Form 8.3 - AstraZeneca
02 May 2014 03:06 PM
BZW
Form 8.3 - AstraZeneca Plc
02 May 2014 02:24 PM
BZW
Form 8.3 - Astrazeneca Plc
02 May 2014 01:41 PM
BZW
Form 8.3 - AstraZeneca PLC
02 May 2014 11:00 AM
RNS
Rule 2.10 Announcement
02 May 2014 10:50 AM
RNS
ASTRAZENECA BOARD REJECTS PFIZER PROPOSAL
02 May 2014 08:09 AM
RNS
STATEMENT REGARDING PFIZER ANNOUNCEMENT
01 May 2014 04:47 PM
BZW
Form 8.3- ASTRAZENECA PLC
01 May 2014 03:28 PM
BZW
Form 8.3 - AstraZeneca Plc
01 May 2014 01:37 PM
BZW
Form 8.3 - AstraZeneca plc
01 May 2014 01:15 PM
BZW
Form 8.3 - AstraZeneca PLC
01 May 2014 11:00 AM
RNS
Rule 2.10 Announcement
01 May 2014 11:00 AM
RNS
Total Voting Rights
30 Apr 2014 03:29 PM
BZW
Form 8.3 - AstraZeneca Plc
30 Apr 2014 02:24 PM
BZW
Form 8.3 - Astrazeneca Plc
30 Apr 2014 02:09 PM
BZW
Form 8.3 - AstraZeneca PLC
30 Apr 2014 11:00 AM
RNS
Rule 2.10 Announcement
29 Apr 2014 04:30 PM
RNS
Rule 2.10 Announcement
29 Apr 2014 03:32 PM
BZW
Form 8.3 - AstraZeneca Plc
29 Apr 2014 02:46 PM
BZW
Form 8.3 - AstraZeneca PLC
29 Apr 2014 01:38 PM
BZW
Form 8.3 - Astrazeneca Plc
29 Apr 2014 10:52 AM
BZW
Form 8.3 - AstraZeneca PLC
29 Apr 2014 08:36 AM
BZW
Form 8.3 - AstraZeneca PLC
28 Apr 2014 11:34 AM
BZW
Form 8.3 - Astrazeneca Plc - Replacement
28 Apr 2014 10:41 AM
BZW
Form 8.3 - Astrazeneca Plc
28 Apr 2014 10:35 AM
RNS
Statement Regarding Pfizer Announcement
24 Apr 2014 05:20 PM
RNS
Result of AGM
24 Apr 2014 07:08 AM
RNS
1st Quarter Results - Part 2
24 Apr 2014 07:08 AM
RNS
1st Quarter Results
23 Apr 2014 09:00 AM
RNS
Notice of Results
01 Apr 2014 02:00 PM
RNS
Director/PDMR Shareholding
01 Apr 2014 11:00 AM
RNS
Total Voting Rights
31 Mar 2014 02:00 PM
RNS
Director/PDMR Shareholding
31 Mar 2014 02:00 PM
RNS
Director/PDMR Shareholding
31 Mar 2014 02:00 PM
RNS
Director/PDMR Shareholding
26 Mar 2014 11:00 AM
RNS
Director/PDMR Shareholding
21 Mar 2014 07:00 AM
RNS
Filing of Annual Report on Form 20-F with SEC
20 Mar 2014 11:00 AM
RNS
Annual Financial Report
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100